There are currently 142 ongoing clinical trials involving Metabolic Syndrome
Of the 142 trials,85 trials are in Phase II
Furthermore, 18 trials are in Phase IV
The global pharmaceutical industry is steadily developing new drugs for Metabolic Syndrome, a Metabolic Disorder condition. The largest number of ongoing clinical trials for Metabolic Syndrome is conducted in the Asia-Pacific region. North America and Europe are among some of the other prominent regions engaged in Metabolic Syndrome-related drug trials.
Isfahan University of Medical Sciences: The leading ongoing Metabolic Syndrome related clinical trial sponsor
Isfahan University of Medical Sciences is the top sponsor for Metabolic Syndrome-related ongoing clinical trials.
University of Guadalajara, Academic Medical Center, National Nutrition and Food Technology Research Institute and Amsterdam University Medical Center are among other notable clinical trial sponsors involved in Metabolic Syndrome. A clinical trial sponsor can be a Company, Government, Individual, or Institution.
United States of America
China
United States of America
Switzerland
United Kingdom
United States of America
United Kingdom
United States of America
Denmark
Don’t wait - discover a universe of connected data & insights with your next search. Browse over 28M data points across 22 industries.
Access more premium companies when you subscribe to Explorer